Trial · NCT03361956
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Parts A and B: Pooled Placebo + Nucleos(t)Ide Analog (NA) | 43 | |
| Overall Study | STARTED | Part A: JNJ-56136379 75 mg (Open Label) | 28 | |
| Overall Study | STARTED | Part A: JNJ-56136379 75 mg + NA | 66 | |
| Overall Study | STARTED | Part B: JNJ-56136379 250 mg (Open-label) | 32 | |
| Overall Study | STARTED | Part B: JNJ-56136379 250 mg + NA | 63 | |
| Overall Study | Currently Not Treated | Parts A and B: Pooled Placebo + Nucleos(t)Ide Analog (NA) | 22 | |
| Overall Study | Currently Not Treated | Part A: JNJ-56136379 75 mg (Open Label) | 28 | |
| Overall Study | Currently Not Treated | Part A: JNJ-56136379 75 mg + NA | 33 | |
| Overall Study | Currently Not Treated | Part B: JNJ-56136379 250 mg (Open-label) | 32 | |
| Overall Study | Currently Not Treated | Part B: JNJ-56136379 250 mg + NA | 33 | |
| Overall Study | Virologically Suppressed | Parts A and B: Pooled Placebo + Nucleos(t)Ide Analog (NA) | 21 | |
| Overall Study | Virologically Suppressed | Part A: JNJ-56136379 75 mg (Open Label) | 0 | |
| Overall Study | Virologically Suppressed | Part A: JNJ-56136379 75 mg + NA | 33 | |
| Overall Study | Virologically Suppressed | Part B: JNJ-56136379 250 mg (Open-label) | 0 | |
| Overall Study | Virologically Suppressed | Part B: JNJ-56136379 250 mg + NA | 30 | |
| Overall Study | COMPLETED | Parts A and B: Pooled Placebo + Nucleos(t)Ide Analog (NA) | 40 | |
| Overall Study | COMPLETED | Part A: JNJ-56136379 75 mg (Open Label) | 24 | |
| Overall Study | COMPLETED | Part A: JNJ-56136379 75 mg + NA | 61 | |
| Overall Study | COMPLETED | Part B: JNJ-56136379 250 mg (Open-label) | 28 | |
| Overall Study | COMPLETED | Part B: JNJ-56136379 250 mg + NA | 58 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03361956/flow